Literature DB >> 10895065

Diffuse mode of tumor cell invasion and expression of mutant p53 protein but not of p21 protein are correlated with treatment failure in oral carcinomas and their metastatic foci.

T Osaki1, T Kimura, Y Tatemoto, L Dapeng, K Yoneda, T Yamamoto.   

Abstract

Lack of control of metastatic foci is the most prevalent cause of death in patients with oral carcinomas, and it is important for tumor control to identify the factors that predispose patients to death. In the present study, we examined 225 patients with oral squamous cell carcinoma and investigated the immunohistopathological characteristics of 43 tumors that led to death, comparing them with those of the non-lethal tumors. In the 43 patients, lack of control of the primary site, lymph node and distant metastatic tumors were noted in 20, 18 and 16 patients, respectively. The mode of tumor cell invasion was closely correlated with death. The diffuse invasion modes of grades 4C and 4D were observed in 15 (34.9%) of the 43 tumors with a poor outcome and in 35 (19.2%) of the 182 controlled tumors (p < 0.02). The expression of p53 was highly correlated with death. Of the tumors with poor prognosis, p53 protein was expressed in 32 tumors (76.2%). However, p53 protein expression was observed in 52.7% of the tumors with good prognosis (p < 0.02). In contrast, the expression of p21 protein in the well-controlled tumors (30.4%) was almost equal to that of the 43 lethal tumors (26.2%). Compared with the ratios of local recurrence, metastases and their treatment failures in the p53-negative grade 1 and 2 tumors, those in the mutant p53-positive grade 3, 4C and 4D tumors were mostly high. These results indicate that measuring p53 protein expression and evaluating the mode of tumor cell invasion are important for oral carcinoma therapy because the expression of mutant p53 protein and the diffuse modes of tumor cell invasion indicate a predisposition toward a poor prognosis. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10895065     DOI: 10.1159/000012135

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  6 in total

1.  P53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection.

Authors:  Lun-Xiu Qin; Zhao-You Tang; Zeng-Chen Ma; Zhi-Quan Wu; Xin-Da Zhou; Qing-Hai Ye; Yuan Ji; Li-Wen Huang; Hu-Liang Jia; Hui-Chuan Sun; Lu Wang
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

Review 2.  The prognostic molecular markers in hepatocellular carcinoma.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

3.  Transforming growth factor beta 1 dysregulation in a human oral carcinoma tumour progression model.

Authors:  S Hsu; J L Borke; J B Lewis; B Singh; A C Aiken; C T Huynh; G S Schuster; G B Caughman; D P Dickinson; A K Smith; T Osaki; X F Wang
Journal:  Cell Prolif       Date:  2002-06       Impact factor: 6.831

Review 4.  Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2004-06-17       Impact factor: 4.553

5.  Synthesis and SAR study of novel peptide aldehydes as inhibitors of 20S proteasome.

Authors:  Yuheng Ma; Bo Xu; Yuan Fang; Zhenjun Yang; Jingrong Cui; Liangren Zhang; Lihe Zhang
Journal:  Molecules       Date:  2011-09-05       Impact factor: 4.411

Review 6.  The role of p21Waf1/CIP1 as a Cip/Kip type cell-cycle regulator in oral squamous cell carcinoma (Review).

Authors:  Mario Pérez-Sayáns; José-Manuel Suárez-Peñaranda; Pilar Gayoso-Diz; Francisco Barros-Angueira; José-Manuel Gándara-Rey; Abel García-García
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2013-03-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.